Browsing by Author "Williams, B"
Now showing items 1-20 of 21
-
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, FLJ; Mach, F; Smulders, YM; Carballo, D; Koskinas, KC; Back, M; Benetos, A; Biffi, A; Boavida, J-M; Capodanno, D (2022) -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Visseren, FLJ; Mach, F; Smulders, YM; Carballo, D; Koskinas, KC; Back, M; Benetos, A; Biffi, A; Boavida, J-M; Capodanno, D (2021-09-07) -
2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action
Campbell, NRC; Whelton, PK; Orias, M; Wainford, RD; Cappuccio, FP; Ide, N; Neal, B; Cohn, J; Cobb, LK; Webster, J (2023) -
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial
Mackenzie, IS; Rogers, A; Poulter, NR; Williams, B; Brown, MJ; Webb, DJ; Ford, I; Rorie, DA; Guthrie, G; Grieve, JWK (2022) -
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Elneima, O; McAuley, HJC; Leavy, OC; Chalmers, JD; Horsley, A; Ho, L-P; Marks, M; Poinasamy, K; Raman, B; Shikotra, A -
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
MacDonald, TM; Williams, B; Webb, DJ; Morant, S; Caulfield, M; Cruickshank, JK; Ford, I; Sever, P; Mackenzie, IS; Padmanabhan, S (2017-11-18)BACKGROUND: Guidelines for hypertension vary in their preference for initial combination therapy or initial monotherapy, stratified by patient profile; therefore, we compared the efficacy and tolerability of these approaches. ... -
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
Brown, MJ; Williams, B; MacDonald, TM; Caulfield, M; Cruickshank, JK; McInnes, G; Sever, P; Webb, DJ; Salsbury, J; Morant, S (2015) -
Deep forecasting of translational impact in medical research
Nelson, APK; Gray, RJ; Ruffle, JK; Watkins, HC; Herron, D; Sorros, N; Mikhailov, D; Cardoso, MJ; Ourselin, S; McNally, N (2022) -
Development of [<SUP>18</SUP>F]AldoView as the First Highly Selective Aldosterone Synthase PET Tracer for Imaging of Primary Hyperaldosteronism
Sander, K; Gendron, T; Cybulska, KA; Sirindil, F; Zhou, J; Kalber, TL; Lythgoe, MF; Kurzawinski, TR; Brown, MJ; Williams, B (2021) -
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
Brown, MJ; Williams, B; Morant, SV; Webb, DJ; Caulfield, MJ; Cruickshank, JK; Ford, I; McInnes, G; Sever, P; Salsbury, J (2016-02) -
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Williams, B; MacDonald, TM; Morant, SV; Webb, DJ; Sever, P; McInnes, GT; Ford, I; Cruickshank, JK; Caulfield, MJ; Padmanabhan, S (2018-06) -
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
Williams, B; MacDonald, TM; Morant, SV; Webb, DJ; Sever, P; McInnes, GT; Ford, I; Cruickshank, JK; Caulfield, MJ; Padmanabhan, S (2018-06)BACKGROUND: In the PATHWAY-2 study of resistant hypertension, spironolactone reduced blood pressure substantially more than conventional antihypertensive drugs. We did three substudies to assess the mechanisms underlying ... -
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.
Task Force for the management of COVID-19 of the European Society of Cardiology; Baigent, C; Windecker, S; Andreini, D; Arbelo, E; Barbato, E; Bartorelli, AL; Baumbach, A; Behr, ER; Berti, S (2022-05-06)AIMS: Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the ... -
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Klionsky, DJ; Abdel-Aziz, AK; Abdelfatah, S; Abdellatif, M; Abdoli, A; Abel, S; Abeliovich, H; Abildgaard, MH; Abudu, YP; Acevedo-Arozena, A (2021-02-08)In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant ... -
Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)
Cosentino, F; Grant, PJ; Aboyans, V; Bailey, CJ; Ceriello, A; Delgado, V; Federici, M; Filippatos, G; Grobbee, DE; Hansen, TB (Elsevier España, 2020-05-01) -
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension
Lobo, MD; de Belder, MA; Cleveland, T; Collier, D; Dasgupta, I; Deanfield, J; Kapil, V; Knight, C; Matson, M; Moss, J (2015-01-01) -
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.
Charchar, FJ; Prestes, PR; Mills, C; Ching, SM; Neupane, D; Marques, FZ; Sharman, JE; Vogt, L; Burrell, LM; Korostovtseva, L (2023-09-13)Hypertension, defined as persistently elevated systolic blood pressure (SBP) >140 mmHg and/or diastolic blood pressure (DBP) at least 90 mmHg (International Society of Hypertension guidelines), affects over 1.5 billion ... -
Mother's and children's ADHD genetic risk, household chaos and children's ADHD symptoms: A gene-environment correlation study.
Agnew-Blais, JC; Wertz, J; Arseneault, L; Belsky, DW; Danese, A; Pingault, J-B; Polanczyk, GV; Sugden, K; Williams, B; Moffitt, TE (2022-10)BACKGROUND: Chaotic home environments may contribute to children's attention-deficit hyperactivity disorder (ADHD) symptoms. However, ADHD genetic risk may also influence household chaos. This study investigated whether ... -
An open letter to The BMJ editors on qualitative research
Greenhalgh, T; Annandale, E; Ashcroft, R; Barlow, J; Black, N; Bleakley, A; Boaden, R; Braithwaite, J; Britten, N; Carnevale, F (2016-02-10) -
S-28-1: CARDIOVASCULAR OUTCOMES IN ADULTS WITH HYPERTENSION WITH EVENING VERSUS MORNING DOSING OF USUAL ANTIHYPERTENSIVES IN THE UK. THE TIME STUDY
MacDonald, TM; Mackenzie, IS; Rogers, A; Poulter, NR; Williams, B; Brown, MJ; Webb, DJ; Ford, I; Rorie, D; Grieve, K (Wolters Kluwer, 2023-01)